The Kinase Inhibitor TKI258 Is Active Against the Novel CUX1-FGFR1 Fusion Detected in a Patient With T-Lymphoblastic Leukemia/Lymphoma and T(7;8)(q22;p11)
Haematologica - Italy
doi 10.3324/haematol.2010.036558
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 17, 2011
Authors
Publisher
Ferrata Storti Foundation (Haematologica)